Editorial: Facial hyperkinesis.
D000818:Animals; D004295:Dihydroxyphenylalanine / Q000009:adverse effects; D004298:Dopamine / Q000502:physiology; D005152:Facial Muscles; D000882:Haplorhini; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced / Q000209:etiology*; D010640:Phenothiazines / Q000009:adverse effects; D012110:Reserpine / Q000009:adverse effects; D013981:Tic Disorders / Q000139:chemically induced / Q000209:etiology* / Q000628:therapy
D010640:Phenothiazines; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D004298:Dopamine